iX Biopharma Balance Sheet

Financials in millions SGD. Fiscal year is July - June.

Millions SGD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	5.77	0.87	1.77	6.52	13.49	6.21
Short-Term Investments	-	0.07	0.07	0.02	0.09	0.01
Cash & Short-Term Investments	5.77	0.94	1.84	6.53	13.59	6.21
Cash Growth	178.95%	-49.27%	-71.79%	-51.91%	118.65%	8.03%
Accounts Receivable	1.44	1.03	1.29	1.25	0.5	0.22
Other Receivables	-	0.91	1.63	1.8	1.48	1.59
Receivables	1.44	1.94	2.92	3.05	1.98	1.82
Inventory	0.88	0.92	1.38	0.96	0.91	1.1
Prepaid Expenses	-	0.41	0.44	0.44	0.37	0.22
Other Current Assets	0.31	-	-	-	-	-
Total Current Assets	8.4	4.21	6.59	10.98	16.84	9.35
Property, Plant & Equipment	7.07	6.72	7.61	8.22	7.72	8.95
Long-Term Investments	-	-	0.01	3.87	2.26	-
Goodwill	0.26	0.27	0.29	0.29	0.31	0.33
Other Intangible Assets	-	-	0	-	0.04	0.09
Long-Term Deferred Tax Assets	-	-	-	1.38	1.28	-
Other Long-Term Assets	0.16	0.09	0.13	0.19	0.07	0.15
Total Assets	15.89	11.28	14.62	24.93	28.52	18.86
Accounts Payable	4.39	1.3	1.26	0.4	0.22	0.55
Accrued Expenses	0.14	2.99	2.87	2.81	2.31	2.31
Current Portion of Long-Term Debt	2.86	4.08	2.49	2.75	3.29	0.42
Current Portion of Leases	0.39	0.27	0.39	0.44	0.24	0.38
Current Income Taxes Payable	0.19	0.18	0.17	0.73	1.76	-
Other Current Liabilities	-	0.14	0.21	0.05	0.04	0.02
Total Current Liabilities	7.96	8.98	7.38	7.18	7.86	3.67
Long-Term Debt	3.19	1.47	2.18	0.57	0.88	3.2
Long-Term Leases	0.3	0.08	0.14	0.58	-	0.24
Other Long-Term Liabilities	0.3	0.39	0.58	0.76	0.04	0.04
Total Liabilities	11.75	10.92	10.28	9.08	8.77	7.15
Common Stock	107.42	100.83	97.45	97.23	94.18	83.34
Retained Earnings	-108.96	-107.12	-96.98	-86.18	-76.57	-71.97
Comprehensive Income & Other	5.68	6.65	3.87	4.8	2.13	0.34
Shareholders' Equity	4.13	0.37	4.34	15.85	19.74	11.71
Total Liabilities & Equity	15.89	11.28	14.62	24.93	28.52	18.86
Total Debt	6.73	5.9	5.2	4.34	4.41	4.24
Net Cash (Debt)	-0.97	-4.97	-3.36	2.2	9.18	1.98
Net Cash Growth	-	-	-	-76.08%	363.97%	7.91%
Net Cash Per Share	-0.00	-0.01	-0.00	0.00	0.01	0.00
Filing Date Shares Outstanding	958.05	887.96	883.34	766.3	764.9	746.17
Total Common Shares Outstanding	958.05	887.96	768.32	766.3	751.19	697.35
Working Capital	0.43	-4.77	-0.8	3.8	8.99	5.68
Book Value Per Share	0.00	0.00	0.01	0.02	0.03	0.02
Tangible Book Value	3.88	0.1	4.05	15.56	19.4	11.3
Tangible Book Value Per Share	0.00	0.00	0.01	0.02	0.03	0.02
Land	2.45	2.38	2.57	2.56	2.73	2.88
Buildings	1.66	1.61	1.74	1.74	1.85	1.97
Machinery	6.92	6.7	6.99	6.71	6.6	7.13
Leasehold Improvements	0.73	0.71	0.76	0.74	0.64	0.25

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.